Skip to main content
SpringerLink
Log in

Peripheral Blood Stem Cell Collection after Intermediate-Dose Cytarabine in Adult Patients with Acute Myeloblastic Leukemia Undergoing Autologous Blood Stem Cell Transplantation in First Complete Remission

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Different strategies for collecting peripheral blood stem cells (PBSC) for autologous blood stem cell transplantation (ABSCT) have been reported for patients with acute myeloblastic leukemia (AML).We compared the clinical results of 2 consecutive protocols in 75 adult patients with AML in first complete remission who underwent ABSCT. In the first 56 patients (group A), PBSC were collected after induction and/or consolidation chemotherapy courses. In the subsequent 19 patients (group B), PBSC collection was done after a further intensification course with intermediate-dose cytarabine and mitoxantrone. Hematopoietic engraftment was similar in the 2 groups, with the median times to reach 0.5x109 neutrophils/L and 20x109 platelets/L being 13 days each in group A, and 12 days and 24 days, respectively, in group B. There were 3 graft failures (all in group A) and 5 transplantation-related deaths (6.6%, 4 in group A and 1 in group B). Although not statistically significant, the 3-year probabilities of both relapse (31% versus 66%; P = .12) and disease-free survival (60% versus 36%; P = .1) compared favorably for group B. Our study suggests that collection of PBSC after additional intensification can result in a better outcome for AML patients who undergo ABSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Szer J, Juttner CA, To LB, et al. Post-remission therapy for acute myeloid leukemia with blood-derived stem cell transplantation: results of a collaborative phase II trial. Int J Cell Cloning. 1992; 10(suppl 1):114–116.

    Article  Google Scholar 

  2. Reiffers J, Körbling M, Labopin M, Henon P, Gorin NC. Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Int J Cell Cloning. 1992;10(suppl 1):111–113.

    Article  Google Scholar 

  3. Körbling M, Fliedner TM, Holle R, et al. Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease- free survival. Bone Marrow Transplant. 1991;7:343–349.

    PubMed  Google Scholar 

  4. Sanz MA, de la Rubia J, Sanz, et al. Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol. 1993;11: 1661–1667.

    Article  PubMed  CAS  Google Scholar 

  5. Schiller G, Lee M, Miller T, et al. Transplantation of autologous peripheral blood progenitor cells procured after high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission. Leukemia. 1997; 11:1533–1539.

    Article  PubMed  CAS  Google Scholar 

  6. Linker CA, Ries CA, Damon LE, et al. Autologous stem cell transplantation for acute myeloid leukemia in first remission. Biol Blood Marrow Transplant. 2000;6:50–57.

    Article  PubMed  CAS  Google Scholar 

  7. Reichle A, Hennemann B, Meidenbauer N, et al. Peripheral blood stem cell transplantation (PBSCT) during consolidation treatment of de novo acute myelogenous leukemia [abstract]. Bone Marrow Transplant. 1997;19(suppl 1):396a.

    Google Scholar 

  8. Martín C, Torres A, León A, et al. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission: role of intensification therapy in outcome. Bone Marrow Transplant. 1998;21:375–382.

    Article  PubMed  Google Scholar 

  9. Tallman MS, Perez W, Keating A, Weisdorf D, Horowitz M. Pretransplant consolidation chemotherapy decreases leukemia relapse after autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML) in first complete remission (CR) [abstract]. Blood. 2001;98(suppl 1):859a.

    Google Scholar 

  10. de la Rubia J, Sanz GF, Martín G, et al. Autologous blood stem cell transplantation for acute myeloblastic leukemia in first remission: intensification therapy before transplantation does not prolong disease-free survival. Haematologica. 1999;84:125–132.

    PubMed  Google Scholar 

  11. Gondo H, Harada M, Miyamoto T, et al. Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant. 1997;20:821–826.

    Article  PubMed  CAS  Google Scholar 

  12. Heil G, Hoelzer D, Sanz MA, et al. A randomized, double-blind placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia: the International Acute Myeloid Leukemia Study Group. Blood. 1997;90:4710–4718.

    PubMed  CAS  Google Scholar 

  13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481.

    Article  Google Scholar 

  14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50: 163–170.

    PubMed  CAS  Google Scholar 

  15. Harrington DP, Fleming TR. A class of rank test procedures for censored survival data. Biometrika. 1982;69:553–566.

    Article  Google Scholar 

  16. Harrington D, Fleming TR. Counting Processes and Survival Analysis. New York, NY:Wiley and Sons; 1991.

    Google Scholar 

  17. Gray RJ. A class of K-sample test for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–1154.

    Article  Google Scholar 

  18. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 1993;12:737–751.

    Article  PubMed  CAS  Google Scholar 

  19. Visani G, Lemoli RM, Isidori A, et al. Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients. Bone Marrow Transplant. 2001;27:829–835.

    Article  PubMed  CAS  Google Scholar 

  20. Carral A, de la Rubia J, Martín G, et al. Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies. Leuk Res. 2003;27:5–12.

    Article  PubMed  CAS  Google Scholar 

  21. Reiffers J. Peripheral blood stem cell transplantation in acute myeloid leukemia: the experience of the Bordeaux Group. Stem Cells. 1995;13(suppl 3):19–22.

    Article  PubMed  Google Scholar 

  22. Cantin G, Marchand-Laroche D, Bouchard MM, Leblond PF. Blood-derived stem cell collection in acute nonlymphoblastic leukemia: predictive factors for a good yield. Exp Hematol. 1989; 17:991–996.

    PubMed  CAS  Google Scholar 

  23. Löwenberg B, Voogt P. Autologous stem cell transplantation and purging. J Clin Oncol. 1996;14:2194–2196.

    Article  PubMed  Google Scholar 

  24. Carlo-Stella C,Tabilio A, Regazzi E, et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant. 1997;20:465–471.

    Article  PubMed  CAS  Google Scholar 

  25. Carral A, de la Rubia J, Martín G, et al. Factors influencing hematopoietic recovery after autologous blood stem cell transplantation in patients with acute myeloblastic leukemia and with non-myeloid malignancies. Bone Marrow Transplant. 2002;29:825–832.

    Article  PubMed  CAS  Google Scholar 

  26. Bensinger W, Appelbaum F, Rowley S, et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol. 1995;13:2547–2555.

    Article  PubMed  CAS  Google Scholar 

  27. Keating S, Suciu S, de Witte T, et al. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia. 2003;17:60–67.

    Article  PubMed  CAS  Google Scholar 

  28. Feller N, Schuurhuis GJ, van der Pol MA, et al. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. Leukemia. 2003;17:68–75.

    Article  PubMed  CAS  Google Scholar 

  29. Meloni G, Vignetti M, Avvisati G, et al. BAVC regimen and autograft for acute myelogenous leukemia in second complete remission. Bone Marrow Transplant. 1996;18:693–698.

    PubMed  CAS  Google Scholar 

  30. Stein AS, O’Donnell M, Slovak ML, et al. Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol. 2003; 21:615–623.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Servicio de Hematología, Hospital Universitario La Fe, Avenida Campanar 21, 4600, Valencia, Spain

    J. de la Rubia, G. Martín, J. Martínez, I. Lorenzo, G. Sanz, I. Jarque, F. Moscardó, C. Jiménez, P. Lorente, A. Camps & M. A. Sanz

Authors
  1. J. de la Rubia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Martín
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Martínez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. Lorenzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. I. Jarque
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Moscardó
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. Jiménez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Lorente
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A. Camps
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M. A. Sanz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Sanz.

About this article

Cite this article

de la Rubia, J., Martín, G., Martínez, J. et al. Peripheral Blood Stem Cell Collection after Intermediate-Dose Cytarabine in Adult Patients with Acute Myeloblastic Leukemia Undergoing Autologous Blood Stem Cell Transplantation in First Complete Remission. Int J Hematol 80, 168–173 (2004). https://doi.org/10.1532/IJH97.E0321

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.E0321

Key words

Search

Navigation